BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26088135)

  • 21. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers.
    Pritchard LK; Vasiljevic S; Ozorowski G; Seabright GE; Cupo A; Ringe R; Kim HJ; Sanders RW; Doores KJ; Burton DR; Wilson IA; Ward AB; Moore JP; Crispin M
    Cell Rep; 2015 Jun; 11(10):1604-13. PubMed ID: 26051934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
    Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
    PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
    Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y
    J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
    Nguyen HT; Madani N; Ding H; Elder E; Princiotto A; Gu C; Darby P; Alin J; Herschhorn A; Kappes JC; Mao Y; Sodroski JG
    Virol J; 2017 Feb; 14(1):33. PubMed ID: 28209172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.
    Staropoli I; Chanel C; Girard M; Altmeyer R
    J Biol Chem; 2000 Nov; 275(45):35137-45. PubMed ID: 10926931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.
    Behrens AJ; Harvey DJ; Milne E; Cupo A; Kumar A; Zitzmann N; Struwe WB; Moore JP; Crispin M
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of a soluble cleaved HIV-1 envelope trimer.
    Julien JP; Cupo A; Sok D; Stanfield RL; Lyumkis D; Deller MC; Klasse PJ; Burton DR; Sanders RW; Moore JP; Ward AB; Wilson IA
    Science; 2013 Dec; 342(6165):1477-83. PubMed ID: 24179159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies.
    Bale S; Martiné A; Wilson R; Behrens AJ; Le Fourn V; de Val N; Sharma SK; Tran K; Torres JL; Girod PA; Ward AB; Crispin M; Wyatt RT
    Front Immunol; 2018; 9():1116. PubMed ID: 29881382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.
    Center RJ; Lebowitz J; Leapman RD; Moss B
    J Virol; 2004 Mar; 78(5):2265-76. PubMed ID: 14963123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins.
    Dey AK; David KB; Lu M; Moore JP
    Virology; 2009 Mar; 385(1):275-81. PubMed ID: 19135223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.
    Guenaga J; Dubrovskaya V; de Val N; Sharma SK; Carrette B; Ward AB; Wyatt RT
    J Virol; 2015 Dec; 90(6):2806-17. PubMed ID: 26719252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.
    Ringe RP; Sanders RW; Yasmeen A; Kim HJ; Lee JH; Cupo A; Korzun J; Derking R; van Montfort T; Julien JP; Wilson IA; Klasse PJ; Ward AB; Moore JP
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18256-61. PubMed ID: 24145402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.
    Ringe RP; Ozorowski G; Yasmeen A; Cupo A; Cruz Portillo VM; Pugach P; Golabek M; Rantalainen K; Holden LG; Cottrell CA; Wilson IA; Sanders RW; Ward AB; Klasse PJ; Moore JP
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.
    Ozorowski G; Pallesen J; de Val N; Lyumkis D; Cottrell CA; Torres JL; Copps J; Stanfield RL; Cupo A; Pugach P; Moore JP; Wilson IA; Ward AB
    Nature; 2017 Jul; 547(7663):360-363. PubMed ID: 28700571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.